Reze, France

Alain Faivre-Chauvet

This inventor holds 1 USPTO granted patent. Top assignees: Centre Hospitalier Universitaire De Nantes, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alain Faivre-Chauvet. Retrieved from https://idiyas.com/inventor/alain-faivre-chauvet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alain Faivre-Chauvet: Innovator in Radiopharmaceuticals

Introduction

Alain Faivre-Chauvet is a notable inventor based in Reze, France. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative patent.

Latest Patents

Faivre-Chauvet holds a patent for "Ionic liquid supported organotin reagents for the manufacturing of radiopharmaceuticals compounds." This patent describes an ionic liquid supported organotin reagent of formula (I). It also outlines a process for manufacturing this reagent, a method for creating halogenated or radio-halogenated compounds using the reagent, a device for implementing the halogenating process, and a kit that includes the compound of formula (I). He has 1 patent to his name.

Career Highlights

Throughout his career, Alain Faivre-Chauvet has worked with esteemed institutions such as Université d'Angers and the Centre National de la Recherche Scientifique. His work has been pivotal in advancing the methodologies used in the production of radiopharmaceuticals.

Collaborations

Faivre-Chauvet has collaborated with talented individuals in his field, including Djibril Faye and Fabien Boeda. Their combined expertise has contributed to the success of his projects and innovations.

Conclusion

Alain Faivre-Chauvet is a distinguished inventor whose work in radiopharmaceuticals has made a lasting impact. His innovative approaches and collaborations continue to influence the field significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…